Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Fardioni-Laurens, L; Bosq, J; Janot, F; Vayssade, M; Le Bihan, ML; Kaghad, M; Caput, D; Benard, J; Ahomadegbe, JC
   P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
   ONCOGENE
   
   L. Fardioni-Laurens et al., "P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?", ONCOGENE, 20(38), 2001, pp. 5302-5312
2. Schwaab, G; Kolb, F; Julieron, M; Janot, F; Le Ridant, AM; Mamelle, G; Marandas, P; Koka, VN; Luboinski, B
   Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Gustave-Roussy experience (146 cases, 1974-1997)
   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
   
   G. Schwaab et al., "Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Gustave-Roussy experience (146 cases, 1974-1997)", EUR ARCH OT, 258(5), 2001, pp. 246-249
3. Ribrag, V; Hajj, ME; Janot, F; Girinsky, T; Domenge, C; Schwaab, G; Fenaux, P; Bosq, J
   Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx
   LEUKEMIA
   
   V. Ribrag et al., "Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx", LEUKEMIA, 15(7), 2001, pp. 1123-1126
4. De Crevoisier, R; Domenge, C; Wibault, P; Koscielny, S; Lusinchi, A; Janot, F; Bobin, S; Luboinski, B; Eschwege, F; Bourhis, J
   Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma
   CANCER
   
   R. De Crevoisier et al., "Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma", CANCER, 91(11), 2001, pp. 2071-2076
5. Guerry, M; Vabre, L; Talbot, M; Mamelle, G; Leridant, AM; Hill, C; Bosq, J; Luboinski, B; Janot, F
   Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma - a reply
   BRITISH JOURNAL OF CANCER
   
   M. Guerry et al., "Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma - a reply", BR J CANC, 82(9), 2000, pp. 1614-1614
6. Badie, C; Bourhis, J; Sobczak-Thepot, J; Haddada, H; Chiron, M; Janicot, M; Janot, F; Tursz, T; Vassal, G
   p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line
   BRITISH JOURNAL OF CANCER
   
   C. Badie et al., "p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line", BR J CANC, 82(3), 2000, pp. 642-650
7. Couteau, C; Chouaki, N; Leyvraz, S; Oulid-Aissa, D; Lebecq, A; Domenge, C; Groult, V; Bordessoule, S; Janot, F; De Forni, M; Armand, JP
   A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
   BRITISH JOURNAL OF CANCER
   
   C. Couteau et al., "A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck", BR J CANC, 81(3), 1999, pp. 457-462
8. RIXE O; GATINEAU M; BATOUCHE M; RAYMOND E; DOMENGE C; JANOT F; SCHWAAB G; LUBOINSKI B; ARMAND JP
   SEQUENTIAL NEOADJUVANT CHEMOTHERAPY (SC) FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC)
   Annals of oncology
   
   O. Rixe et al., "SEQUENTIAL NEOADJUVANT CHEMOTHERAPY (SC) FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC)", Annals of oncology, 9, 1998, pp. 672-672
9. DECREVOISIER R; BOURHIS J; DOMENGE C; WIBAULT P; KOSCIELNY S; LUSINCHI A; MAMELLE G; JANOT F; JULIERON M; LERIDANT AM; MARANDAS P; ARMAND JP; SCHWAAB G; LUBOINSKI B; ESCHWEGE F
   FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS
   Journal of clinical oncology
   
   R. Decrevoisier et al., "FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS", Journal of clinical oncology, 16(11), 1998, pp. 3556-3562
10. MASSAADMASSADE L; DOMENGE C; RONGEAT S; HASSOUN L; LEGROS MH; ROPERS J; JANOT F; PARISE O; GOUYETTE A
    RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/
    Anticancer research
    
    L. Massaadmassade et al., "RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/", Anticancer research, 18(1A), 1998, pp. 283-288
11. KOKA VN; JULIERON M; BOURHIS J; JANOT F; LERIDANT AM; MARANDAS P; LUBOINSKI B; SCHWAAB G
    AESTHESIONEUROBLASTOMA
    Journal of Laryngology and Otology
    
    V.N. Koka et al., "AESTHESIONEUROBLASTOMA", Journal of Laryngology and Otology, 112(7), 1998, pp. 628-633
12. SALVAN D; JULIERON M; MARANDAS P; JANOT F; LERIDANT AM; DOMENGE C; MAMELLE G; SCHWAAB G; LUBOINSKI B
    COMBINED TRANSFACIAL AND NEUROSURGICAL APPROACH TO MALIGNANT-TUMORS OF THE ETHMOID SINUS
    Journal of Laryngology and Otology
    
    D. Salvan et al., "COMBINED TRANSFACIAL AND NEUROSURGICAL APPROACH TO MALIGNANT-TUMORS OF THE ETHMOID SINUS", Journal of Laryngology and Otology, 112(5), 1998, pp. 446-450
13. VIEGAS LC; PARISE O; TALBOT M; KOWALSKI LP; LUBOINSKI B; JANOT F; BOSQ J
    LOSS OF C-ERB-B2 EXPRESSION AND TUMOR PROGRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC)
    British Journal of Cancer
    
    L.C. Viegas et al., "LOSS OF C-ERB-B2 EXPRESSION AND TUMOR PROGRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC)", British Journal of Cancer, 77, 1998, pp. 127-127
14. JANOT F; GUERRY M; VABRE L; TALBOT M; LERIDANT AM; MAMELLE G; HILL C; BOSQ J; LUBOINSKI B
    ABSENCE OF C-ERB-B2 EXPRESSION AND RISK OF DISTANT METASTASIS IN PHARYNGEAL TUMORS
    British Journal of Cancer
    
    F. Janot et al., "ABSENCE OF C-ERB-B2 EXPRESSION AND RISK OF DISTANT METASTASIS IN PHARYNGEAL TUMORS", British Journal of Cancer, 77, 1998, pp. 128-128
15. DOMENGE C; BATOUCHE M; BELLAMY J; DARTEVELLE P; JANOT F; MARANDAS P; LUBOINSKI B
    RESECTION OF LUNG NEOPLASTIC NODULES LONG-TERM BENEFIT SURVIVAL FROM HEAD AND NECK-CANCER PATIENTS
    British Journal of Cancer
    
    C. Domenge et al., "RESECTION OF LUNG NEOPLASTIC NODULES LONG-TERM BENEFIT SURVIVAL FROM HEAD AND NECK-CANCER PATIENTS", British Journal of Cancer, 77, 1998, pp. 148-148
16. Guerry, M; Vabre, L; Talbot, M; Mamelle, G; Leridant, AM; Hill, C; Bosq, J; Luboinski, B; Janot, F
    Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study
    BRITISH JOURNAL OF CANCER
    
    M. Guerry et al., "Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study", BR J CANC, 77(11), 1998, pp. 1932-1936
17. FORTIN A; GUERRY M; GUERRY R; TALBOT M; PARISE O; SCHWAAB G; BOSQ J; BOURHIS J; SALVATORI P; JANOT F; BUSSON P
    CHROMOSOME 11Q13 GENE AMPLIFICATIONS IN ORAL AND OROPHARYNGEAL CARCINOMAS - NO CORRELATION WITH SUBCLINICAL LYMPH-NODE INVASION AND DISEASERECURRENCE
    Clinical cancer research
    
    A. Fortin et al., "CHROMOSOME 11Q13 GENE AMPLIFICATIONS IN ORAL AND OROPHARYNGEAL CARCINOMAS - NO CORRELATION WITH SUBCLINICAL LYMPH-NODE INVASION AND DISEASERECURRENCE", Clinical cancer research, 3(9), 1997, pp. 1609-1614
18. SCHWAAB G; JULIERON M; JANOT F
    EPIDEMIOLOGY OF UPPER AERODIGESTIVE TRACT CANCER
    Neuro-chirurgie
    
    G. Schwaab et al., "EPIDEMIOLOGY OF UPPER AERODIGESTIVE TRACT CANCER", Neuro-chirurgie, 43(2), 1997, pp. 61-63
19. CLAYMAN GL; LIU TJ; OVERHOLT SM; MOBLEY SR; WANG M; JANOT F; GOEPFERT H
    GENE-THERAPY FOR HEAD AND NECK-CANCER - COMPARING THE TUMOR-SUPPRESSOR GENE P53 AND A CELL-CYCLE REGULATOR WAF1 CIP1 (P21)/
    Archives of otolaryngology, head & neck surgery
    
    G.L. Clayman et al., "GENE-THERAPY FOR HEAD AND NECK-CANCER - COMPARING THE TUMOR-SUPPRESSOR GENE P53 AND A CELL-CYCLE REGULATOR WAF1 CIP1 (P21)/", Archives of otolaryngology, head & neck surgery, 122(5), 1996, pp. 489-493
20. WIBAULT P; BENSMAINE MEA; DEFORNI M; ARMAND JP; BERNAL ET; GUILLOT T; RECONDO G; DOMENGE C; JANOT F; BOREL C; LUBOINSKI B; ESCHWEGE F; CVITKOVIC E
    INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL
    Journal of clinical oncology
    
    P. Wibault et al., "INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL", Journal of clinical oncology, 14(4), 1996, pp. 1192-1200
21. BOURHIS J; DENDALE R; HILL C; BOSQ J; JANOT F; ATTAL P; FORTIN A; MARANDAS P; SCHWAAB G; WIBAULT P; MALAISE EP; BOBIN S; LUBOINSKI B; ESCHWEGE F; WILSON G
    POTENTIAL DOUBLING TIME AND CLINICAL OUTCOME IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA TREATED WITH 70 GY IN 7 WEEKS
    International journal of radiation oncology, biology, physics
    
    J. Bourhis et al., "POTENTIAL DOUBLING TIME AND CLINICAL OUTCOME IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA TREATED WITH 70 GY IN 7 WEEKS", International journal of radiation oncology, biology, physics, 35(3), 1996, pp. 471-476
22. BENSMAINE MEA; GUILLOT T; BERNAL ET; JANOT F; SIGAL R; DOMENGE C; WIBAULT P; ARMAND JP; CVITKOVIC E
    NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN-VINDESINE-5-FLUOSOURACIL AND FOLINIC ACID FOR LOCALLY ADVANCED HEAD AND NECK-CARCINOMA
    American journal of clinical oncology
    
    M.E.A. Bensmaine et al., "NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN-VINDESINE-5-FLUOSOURACIL AND FOLINIC ACID FOR LOCALLY ADVANCED HEAD AND NECK-CARCINOMA", American journal of clinical oncology, 19(4), 1996, pp. 356-362
23. JANOT F; KLIJANIENKO J; RUSSO A; MAMET JP; DEBRAUD F; ELNAGGAR AK; PIGNON JP; LUBOINSKI B; CVITKOVIC E
    PROGNOSTIC VALUE OF CLINICOPATHOLOGICAL PARAMETERS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PROSPECTIVE ANALYSIS
    British Journal of Cancer
    
    F. Janot et al., "PROGNOSTIC VALUE OF CLINICOPATHOLOGICAL PARAMETERS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PROSPECTIVE ANALYSIS", British Journal of Cancer, 73(4), 1996, pp. 531-538
24. RIBRAG V; MASSAAD L; JANOT F; MORIZET J; GOUYETTE A; CHABOT GG
    MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY
    Leukemia & lymphoma
    
    V. Ribrag et al., "MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY", Leukemia & lymphoma, 18(3-4), 1995, pp. 303-310
25. DOMENGE C; MASSADE L; RONGEAT S; HASSOUN L; LEGROS MH; JANOT F; JULIERON M; LUBOINSKI B; GOUYETTE A
    GLUTATHIONE SYSTEM AND CHEMORESPONSE TO 5-FLUOROURACIL AND CISPLATINEIN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PILOT-STUDY
    European journal of cancer
    
    C. Domenge et al., "GLUTATHIONE SYSTEM AND CHEMORESPONSE TO 5-FLUOROURACIL AND CISPLATINEIN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PILOT-STUDY", European journal of cancer, 31A, 1995, pp. 402-402
26. JANOT F; ELNAGGAR AK; MORRISON RS; LIU TJ; TAYLOR DL; CLAYMAN GL
    EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK IS ASSOCIATED WITH DEGREE OF HISTOLOGIC DIFFERENTIATION
    International journal of cancer
    
    F. Janot et al., "EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK IS ASSOCIATED WITH DEGREE OF HISTOLOGIC DIFFERENTIATION", International journal of cancer, 64(2), 1995, pp. 117-123
27. KLIJANIENKO J; ELNAGGAR AK; DEBRAUD F; RODRIGUEZPERALTO JL; RODRIGUEZ R; ITZHAKI M; RUSSO A; JANOT F; LUBOINSKI B; CVITKOVIC E
    TUMOR VASCULARIZATION, MITOTIC INDEX, HISTOPATHOLOGIC GRADE, AND DNA-PLOIDY IN THE ASSESSMENT OF 114 HEAD AND NECK SQUAMOUS-CELL CARCINOMAS
    Cancer
    
    J. Klijanienko et al., "TUMOR VASCULARIZATION, MITOTIC INDEX, HISTOPATHOLOGIC GRADE, AND DNA-PLOIDY IN THE ASSESSMENT OF 114 HEAD AND NECK SQUAMOUS-CELL CARCINOMAS", Cancer, 75(7), 1995, pp. 1649-1656
28. PARISE O; JANOT F; LUBOINSKI B; MASSAAD L; ALBIN N; TOUSSAINT C; VERJUS MA; BONNAY M; GOUYETTE A; CHABOT GG
    THYMIDYLATE SYNTHASE ACTIVITY, FOLATES, AND GLUTATHIONE SYSTEM IN HEAD AND NECK-CARCINOMA AND ADJACENT TISSUES
    Head & neck
    
    O. Parise et al., "THYMIDYLATE SYNTHASE ACTIVITY, FOLATES, AND GLUTATHIONE SYSTEM IN HEAD AND NECK-CARCINOMA AND ADJACENT TISSUES", Head & neck, 16(2), 1994, pp. 158-164
29. PARISE O; JANOT F; GUERRY R; FORTIN A; LUBOINSKI B; TURSZ T; SCHWAAB G; BUSSON P
    CHROMOSOME-11Q13 GENE AMPLIFICATIONS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - RELATION WITH LYMPH-NODE INVASION
    International journal of oncology
    
    O. Parise et al., "CHROMOSOME-11Q13 GENE AMPLIFICATIONS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - RELATION WITH LYMPH-NODE INVASION", International journal of oncology, 5(2), 1994, pp. 309-313
30. GIRINSKY T; BERNHEIM A; LUBIN R; TAVAKOLIRAZAVI T; BAKER F; JANOT F; WIBAULT P; COSSET JM; DUVILLARD P; DUVERGER A; FERTIL B
    IN-VITRO PARAMETERS AND TREATMENT OUTCOME IN HEAD AND NECK CANCERS TREATED WITH SURGERY AND OR RADIATION - CELL CHARACTERIZATION AND CORRELATIONS WITH LOCAL-CONTROL AND OVERALL SURVIVAL/
    International journal of radiation oncology, biology, physics
    
    T. Girinsky et al., "IN-VITRO PARAMETERS AND TREATMENT OUTCOME IN HEAD AND NECK CANCERS TREATED WITH SURGERY AND OR RADIATION - CELL CHARACTERIZATION AND CORRELATIONS WITH LOCAL-CONTROL AND OVERALL SURVIVAL/", International journal of radiation oncology, biology, physics, 30(4), 1994, pp. 789-794
31. RIBRAG V; MASSAAD L; JANOT F; BISSERY MC; PARISE O; GOUYETTE A; CHABOT GG
    PRINCIPAL DRUG-METABOLIZING ENZYME-SYSTEMS IN L1210 LEUKEMIA SENSITIVE OR RESISTANT TO BCNU IN-VIVO
    Leukemia research
    
    V. Ribrag et al., "PRINCIPAL DRUG-METABOLIZING ENZYME-SYSTEMS IN L1210 LEUKEMIA SENSITIVE OR RESISTANT TO BCNU IN-VIVO", Leukemia research, 18(11), 1994, pp. 829-835
32. ROUX FX; BRASNU D; DEVAUX B; CHABARDES E; SCHWAAB G; LACCOURREYE O; MENARD M; JANOT F; NGUYEN S; BERTRAND J; MEDER JF
    ETHMOID SINUS CARCINOMAS - RESULTS AND PROGNOSIS AFTER NEOADJUVANT CHEMOTHERAPY AND COMBINED SURGERY - A 10-YEAR EXPERIENCE
    Surgical neurology
    
    F.X. Roux et al., "ETHMOID SINUS CARCINOMAS - RESULTS AND PROGNOSIS AFTER NEOADJUVANT CHEMOTHERAPY AND COMBINED SURGERY - A 10-YEAR EXPERIENCE", Surgical neurology, 42(2), 1994, pp. 98-104
33. BOURHIS J; WILSON G; WIBAULT P; BOSQ J; ARMAND JP; LUBOINSKI B; MALAISE EP; ESCHWEGE F; JANOT F
    RAPID TUMOR-CELL PROLIFERATION AFTER INDUCTION CHEMOTHERAPY IN OROPHARYNGEAL CANCER
    The Laryngoscope
    
    J. Bourhis et al., "RAPID TUMOR-CELL PROLIFERATION AFTER INDUCTION CHEMOTHERAPY IN OROPHARYNGEAL CANCER", The Laryngoscope, 104(4), 1994, pp. 468-472
34. JANOT F; CVITKOVIC E; PIEKARSKI JD; SIGAL R; ARMAND JP; BENSMAINE A; LUBOINSKI B
    CORRELATION BETWEEN NODAL DENSITY IN CONTRASTED SCANS AND RESPONSE TOCISPLATIN-BASED CHEMOTHERAPY IN HEAD AND NECK SQUAMOUS-CELL CANCER - A PROSPECTIVE VALIDATION
    Head & neck
    
    F. Janot et al., "CORRELATION BETWEEN NODAL DENSITY IN CONTRASTED SCANS AND RESPONSE TOCISPLATIN-BASED CHEMOTHERAPY IN HEAD AND NECK SQUAMOUS-CELL CANCER - A PROSPECTIVE VALIDATION", Head & neck, 15(3), 1993, pp. 222-229
35. JANOT F; STRAZIELLE C; DASILVA MAP; CUSSENOT O
    ADAPTATION OF FACIAL ARCHITECTURE IN THE TOULOUSE DEFORMITY (23.10.92)
    Surgical and radiologic anatomy
    
    F. Janot et al., "ADAPTATION OF FACIAL ARCHITECTURE IN THE TOULOUSE DEFORMITY (23.10.92)", Surgical and radiologic anatomy, 15(1), 1993, pp. 75-76
36. KLIJANIENKO J; ELNAGGAR A; DEBRAUD F; MICHEAU C; JANOT F; LUBOINSKI B; GENTILE A; RUSSO A; CVITKOVIC E
    KERATIN-6, KERATIN-13 AND KERATIN-19 - DIFFERENTIAL EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    Analytical and quantitative cytology and histology
    
    J. Klijanienko et al., "KERATIN-6, KERATIN-13 AND KERATIN-19 - DIFFERENTIAL EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK", Analytical and quantitative cytology and histology, 15(5), 1993, pp. 335-340
37. BOURHIS J; WILSON G; WIBAULT P; BOSQ J; CHAVAUDRA N; JANOT F; LUBOINSKI B; ESCHWEGE F; MALAISE EP
    IN-VIVO MEASUREMENT OF THE POTENTIAL DOUBLING TIME BY FLOW-CYTOMETRICIN OROPHARYNGEAL CANCER TREATED BY CONVENTIONAL RADIOTHERAPY
    International journal of radiation oncology, biology, physics
    
    J. Bourhis et al., "IN-VIVO MEASUREMENT OF THE POTENTIAL DOUBLING TIME BY FLOW-CYTOMETRICIN OROPHARYNGEAL CANCER TREATED BY CONVENTIONAL RADIOTHERAPY", International journal of radiation oncology, biology, physics, 26(5), 1993, pp. 793-799
38. JANOT F; MASSAAD L; RIBRAG V; DEWAZIERS I; BEAUNE PH; LUBOINSKI B; PARISE O; GOUYETTE A; CHABOT GG
    PRINCIPAL XENOBIOTIC-METABOLIZING ENZYME-SYSTEMS IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    Carcinogenesis
    
    F. Janot et al., "PRINCIPAL XENOBIOTIC-METABOLIZING ENZYME-SYSTEMS IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA", Carcinogenesis, 14(7), 1993, pp. 1279-1283
39. MASSAAD L; DEWAZIERS I; RIBRAG V; JANOT F; MORIZET J; BEAUNE PH; GOUYETTE A; CHABOT GG
    SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS
    Bulletin du cancer
    
    L. Massaad et al., "SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS", Bulletin du cancer, 80(5), 1993, pp. 397-407